106. Cryopyrin-associated periodic syndrome Clinical trials / Disease details


Clinical trials : 42 Drugs : 24 - (DrugBank : 4) / Drug target genes : 4 - Drug target pathways : 48

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04524858
(ClinicalTrials.gov)
October 23, 202019/8/2020Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)A Phase 2a, Open-Label, Single-Arm Study to Investigate the Safety and Efficacy of ATI-450 for the Maintenance of Remission in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS) Previously Managed With Anti-IL-1 TherapyCryopyrin-Associated Periodic SyndromeDrug: ATI-450Aclaris Therapeutics, Inc.NULLTerminated18 YearsN/AAll1Phase 2United States